Science|Business Reporting

Biotech and pharma companies have overtaken the technology sector in the European Commission’s annual scoreboard of R&D investment for the first time.

The European Commission wants to remove the stigma of bankruptcy and give entrepreneurs a second chance.

The Green Paper on the formation of a European Research Area attracted more than 800 responses by the time the consultation came to an end this week.